diffuse large B-cell lymphoma

Research in Review

Novel Prognostic Biomarker Identified in DLBCL

06/23/2017

JCP Editors

A new prognostic indicator involving monocytes has been identified for patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), according to research presented at the 22nd Congress of the European...

A new...

06/23/2017

Journal of Clinical Pathways

Research in Review

DLBCL Survival Outcomes Improved With Combination Therapy

06/22/2017

JCP Editors

Patients with diffuse large B-cell lymphoma (DLBCL) benefit from improved survival outcomes when treated with a combination therapy rather than monotherapy, according to research presented at the 22nd Congress of the...

...

06/22/2017

Journal of Clinical Pathways

Research in Review

Analyzing DLBCL Circulating Tumor DNA Helps Predict Treatment Response

05/31/2017

JCP Editors

Noninvasive sampling of diffuse large B-cell lymphoma (DLBCL) circulating tumor DNA enables early detection of focal and broad somatic copy number alterations, according to research that will be presented at the 2017...

...

05/31/2017

Journal of Clinical Pathways

Research in Review

Lenalidomide Maintenance Prolongs PFS in Older Patients With Diffuse B-Cell Lymphoma

05/12/2017

JCP Editors

Lenalidomide maintenance therapy for 24 months after obtaining a complete or partial response to standard chemotherapy significantly prolongs progression-free survival (PFS) in older patients with diffuse large...

...

05/12/2017

Journal of Clinical Pathways

Research in Review

Lenalidomide Maintenance Prolongs PFS in Older Patients With Diffuse Large B-Cell Lymphoma

04/28/2017

JCP Editors

Lenalidomide maintenance therapy for 24 months after a complete or partial response to standard chemotherapy significantly prolongs progression-free survival (PFS) in older patients with diffuse large B-cell...

...

04/28/2017

Journal of Clinical Pathways

Research in Review

New Prognostic Marker Identified for Diffuse Large B-Cell Lymphoma

04/27/2017

JCP Editors

A recent meta-analysis identified a strong correlation between an inflammation marker and survival outcomes for patients with diffuse large B-cell lymphoma, published in PLOS One (published online April 25, 2017;...

A...

04/27/2017

Journal of Clinical Pathways

Research in Review

Maintenance Therapy Effective in Treating Diffuse Large B-Cell Lymphoma

04/12/2017

JCP Editors

Maintenance therapy with a targeting agent may provide survival benefits beyond first- and second-line chemotherapy in patients with diffuse large B-cell lymphoma, according to an analysis published in PLOS One...

...

04/12/2017

Journal of Clinical Pathways